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Orthopaedic oncology is a relatively new specialty which has
evolved rapidly in the past 25 years thanks to advances in diag-
nostic imaging, chemotherapy, surgical techniques and reconstruc-
tive methods. The pioneer in establishing orthopaedic oncology as
an international specialty was, without doubt, William Enneking,
who continues to be active teaching, guiding and instructing
throughout the world. This book has been written by his disciples
and is a distillation of the last 25 years’ experience with a strong
emphasis on the North American experience. The two Editors both
have impeccable pedigrees and have written widely on the subject,
as have their seven assistant Editors and most of the 54 contribu-
tors, of whom only three do not come from North America.
Despite its North American bias, this book is well written and
beautifully illustrated. It takes the reader through the journey from
presentation, through diagnosis, to a whole range of surgical treat-
ments for both benign and malignant conditions. The book is well-
structured with the first section discussing the basic science and
general principles of treatment; there are then further sections
dealing with benign bone tumours, malignant bone tumours, soft
tissue tumours and, finally, metastatic disease presenting in bones.
All of the chapters are written by recognized authorities.
As a recipe book this is one of the few texts currently available
to offer a broad review of the various options for surgical manage-
ment of any one condition, both in terms of diagnosis and in terms
of location. There are clear line drawings detailing how to do some
of the more complicated operations and sensible advice about
management.
It is clearly recognized from every chapter that the first role of
the Orthopaedic Oncologist is to adequately resect the tumour, and
considerable emphasis is placed on this. The second part of the job
is the reconstructive process, and this is well addressed in most
chapters with an emphasis often being determined by the indi-
vidual author’s preference. As such, one of the deficiencies is the
absence of a well-argued case posing the benefits and disadvan-
tages of various types of reconstruction. To a certain extent this is
not surprising as even long-term comparisons have, in some
instances, failed to show clear cut differences between prosthetic
replacements, allografts and other forms of reconstruction.
This book does not take the place of adequate training in
orthopaedic oncology and, as such, should not be used by the
occasional operator. It is a book that is an essential complement to
any Orthopaedic Oncology Department and will also be useful for
anyone dealing with soft tissue sarcomas or with a special interest
in metastatic disease to bone. Given the rarity of bone and soft
tissue sarcomas, and the increasing recognition that centralization
of treatment is important, this book is unlikely to have a large
circulation, but those who use it will value it greatly.
One omission I would like to see corrected in future volumes is
the lack of any detailed discussion about amputations and
outcomes following this form of treatment. The elegant and
complex operations described in this book may appear attractive to
both surgeon and patient, yet a straightforward amputation may be
oncologically and functionally better in many situations and this
alternative should never be forgotten.
RJ Grimer
Royal Orthopaedic Hospital Oncology Service,
The Royal Orthopaedic NHS Trust,
Woodlands, Northfield,
Birmingham
B31 2AP, UK
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It was a pleasure to review this book for two main reasons. First,
unlike the vast majority of modern texts it is written by a single
author and therefore brings a very personal view of his expertise to
the reader. Secondly, one reads the book in the knowledge that the
author is an active specialist in breast disease and that the opinions
given are based on true experience in clinical practice.
There are 24 chapters covering all aspects of breast cancer, with
the exception of metastatic disease. It is therefore very much a
book for clinical surgeons. Each of the chapters is clearly written
and is extremely well supported by an exhaustive list of refer-
ences. The references, I am pleased to note, list data from many
international centres and do not concentrate solely on the North
American literature, which is a great limitation of a number of
American texts.
Inevitably, there are the occasional weaknesses. For example,
the chapter on breast reconstruction might be regarded as being
somewhat brief for 1998. Similarly, psychological aspects of
breast cancer are rather scantily addressed.
Despite the above minor criticisms, and the fact that this very
individual book is occasionally somewhat iconoclastic, I found it a
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mend it to both libraries and any surgeon with an interest in breast
disease.
M Greenall,
Department of Surgery,
Oxford Radcliffe Hospital,
Level 2, Headley Way,
Headington,
Oxford OX3 9DU, UK
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This little book aims to assist head and neck cancer ‘care
providers’ to keep up-to-date on new developments in the field.
It highlights 12 areas in which significant advances have been
made over the past few years. Five of these concern surgical
techniques.
There is a chapter entitled ‘Biology of upper aerodigestive tract
carcinoma’ that succinctly but comprehensively covers the topics
of tumour cell kinetics, apoptosis, regulation of proliferation and
mechanism of invasion, with over 100 references. The author
concludes that ‘molecular advances in the field of gene therapy
show great potential for improving disease control’. The reader is
left reflecting that this potential is yet to be realized.
There is a brief but comprehensive review of hyperfractionated
and accelerated radiotherapy for head and neck squamous carci-
noma, similar to many others that have appeared in the literature
over the past few years. The section on rhabdomyosarcoma of the
head and neck in children is a good, balanced review of the
subject. The author rightly warns against the use, outside of a
research setting, of the chemotherapy-only approach now in
vogue, stating that the desire to avoid radiotherapy risks a higher
local recurrence rate and, consequently, the need for more muti-
lating salvage surgery or high-dose chemotherapy.
The editor describes his latest results of high-dose intra-arterial
cisplatin concomitant with radiotherapy for advanced disease. He
claims a loco-regional control at 30 months of 85% in 78 patients,
without so far observing enhanced morbidity, making out a good
case for further investigation of this approach.
A concise account of functional assessment of patients treated
for head and neck cancer describes simple and straightforward
methods for assessing the impact of treatment on patients’ way of
life. Perhaps significantly, this follows two chapters about surgical
management of early laryngeal cancer, in which the authors appear
completely to discount radiotherapy as an alternative approach. By
way of contrast, the last chapter in the book, entitled ‘Quality of
life, co-morbidity and cost-effectiveness in head and neck cancer
treatment’, describes in detail the various methods that have been
used to ‘measure’ quality of life in head and neck cancer patients.
One is left wondering how much reliance can be placed on studies
that regard symptoms scores as measurements to which parametric
statistical tests can be applied.
The price is modest, so this book should find a place in the
libraries of head and neck oncology centres.
Dr JM Henk
Dept of Radiotherapy & Oncology
The Royal Marsden Hospital
Fulham Road
London SW3 6JJ
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European School of Oncology Scientific Updates, 1
This volume heralds the first in a new series from the European
School of Oncology which tackles timely issues in oncology and
aims to produce a rapid, state of the art book which will be of
interest to both pre-clinical and clinical researchers, as well as to
students. Not surprisingly, p53 was selected as the first subject in
view of its important role in the development and progression of
cancer and its implications for treatment.
The book was conceived as the final aim of a Task Force
Meeting that took place in London on 3–4 December 1996. This
meeting discussed a variety of aspects of p53, but focused on the
predictive value of p53 regarding the response to different treat-
ment modalities and its role in treatment resistance. The papers
were written in 1997.
The book consists of ten chapters, six of which are concerned
with breast cancer. The topics include the significance of different
subgroups of p53 mutation, the prognostic and predictive signifi-
cance of p53 determined by mutation analysis, immunohistochem-
istry and luminometric immunoassay, the impact on response to
therapy, its relationship and interaction with other factors, its role
in angiogenesis, its role in breast cancer risk assessment and its
potential as a target for gene therapy. The first chapter sets the
style of the book; it is a reader-friendly background to p53, written
by Thierry Soussi, which gives a taste of some of the major areas
where p53 may have clinical impact. The remaining chapters are
interspersed with a significant amount of new or unpublished data
alongside extensive reviews of the literature. Indeed, considerable
effort has been spent in collating the wealth of information to be
found in the scientific literature. This has resulted in several infor-
mative tables that will be of help and interest to researchers in the
field, as well as to clinicians who wish to understand the potential
value of p53.
The book highlights the contention that surrounds the clinical
utility of p53. The lack of consensus in the scientific literature is
mirrored in the book. A chapter by Anne-Lise Borreson-Dale
describes the role of p53 as pivotal in determining biological
behaviour of breast cancer and that it may accurately predict the
response to different therapeutic interventions. Richard Elledge is
more cautious and suggests it is unclear whether p53 will provide
additional information to predict response to systemic therapy in
breast cancer. The consequence is that there is no clear message as
to the definitive role for p53 in the clinical management of the
cancer patient. However, this is the correct interpretation of the
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including well-designed prospective clinical trials and accurate
and reproducible methods to assess p53 function, before clinical
decisions can be made based on the status of this gene alone or in
combination with other factors. It is clear that p53 has not yet
made the transition from a prognostic to a predictive marker but
the promise for future developments remains encouraging.
The book will be a useful addition to people, both in and on the
periphery, of p53 research in oncology. As with all books of this
type, there is scope for improvement. There is certainly a degree of
repetition between the chapters in describing the basic concepts
and biological properties of p53. It would have been germane for
the editor to finish with a final summary where the relevant infor-
mation was extracted from each chapter and incorporated into a
global and informed view. Even this book will be rapidly out of
date due to constant accumulation of new knowledge in the p53
field. However, this series looks set to provide interesting future
publications and it would be propitious to revisit this particular
subject in the not too distant future.
GD Wilson,
CRC Gray Laboratory
PO Box 100
Mount Vernon Hospital
Northwood
Middlesex HA6 2JR
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